Draig Therapeutics
PrivateLast Round
Series B
Jul 14, 2026
Total Funding Raised
$205M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Draig Therapeutics is a biotechnology company that develops small molecule therapies for neuropsychiatric disorders, including major depressive disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Draig Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Draig Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 14, 2026 | ||||
| Series A | Jun 18, 2025 | ||||
| Seed | Sep 1, 2024 |
Key People
Founding team and executive leadership
Draig Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series B |
| SV Health Investors | Series A, Seed |
| Intermediate Capital Group | Series A |
| British Business Bank | Series B |
| Deep Track Capital | Series B |
| Jefferson Life Sciences | Series B |
| Canaan Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
Monthly visitors increased 127% MoM, reaching 2.1K.
- May 9, 2026
Grew 22% QoQ, from 32 to 39 employees.
Draig Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Draig Therapeutics's valuation, stock price, and market status.